Teprotumumab for the treatment of chronic thyroid eye disease.
Ugradar S, Kang J, Kossler AL, Zimmerman E, Braun J, Harrison AR, Bose S, Cockerham K, Douglas RS.
Ugradar S, et al. Among authors: kossler al.
Eye (Lond). 2022 Aug;36(8):1553-1559. doi: 10.1038/s41433-021-01593-z. Epub 2021 Jul 9.
Eye (Lond). 2022.
PMID: 34244669
Free PMC article.